Table 3.
Treatment groups | TC | LDL | HDL | VLDL | |
---|---|---|---|---|---|
Controls | Normal | 66.03 ± 6.97a | 37.51 ± 3.82a | 12.67 ± 0.01a | 15.85 ± 0.06a |
Infected | 171.78 ± 8.70b | 99.25 ± 8.46b | 31.31 ± 0.01b | 41.22 ± 0.02b | |
Aqueous extract | AQ100 | 146.42 ± 4.34c | 93.70 ± 2.78b | 19.29 ± 0.25c | 33.68 ± 0.02c |
AQ250 | 150.94 ± 9.54b,c | 96.60 ± 6.10b | 16.60 ± 0.11d | 37.74 ± 0.02d | |
AQ500 | 172.00 ± 8.35b | 110.08 ± 5.34b | 22.36 ± 0.01e | 39.56 ± 0.06e | |
Reference drug | CQ | 111.56 ± 4.99d | 71.40 ± 3.19c | 13.39 ± 0.01f | 26.78 ± 0.02f |
Results are means ± SEM of eight independent determinations. Values in the same row carrying different superscripts are significant (P < 0.05) from each other.
Note. P-CTR: positive control mice; N-CTR: negative control mice; AQ100: infected group treated with 100 mg/kg G. lucidum; AQ250: infected group treated with 250 mg/kg G. lucidum; AQ500: infected mice treated with 500 mg/kg G. lucidum; CQ: infected mice treated with chloroquine.